H2B: A Protein Essential for Chromosome Structure and Function

H2B: A Protein Essential for Chromosome Structure and Function

Histone H2B is a protein that plays a critical role in the structure and function of chromosomes. It is a key component of the histone complex, which is responsible for organizing and maintaining the structure of chromosomes during cell division. H2B is composed of several isoforms, including H2B1, H2B2, H2B3, and H2B4, each with a different isoelectric point (pI).

H2B1, also known as H2B.p1, is the most abundant isoform and is widely expressed in various tissues and cells. It is made up of 116 amino acids and has a pI of approximately 9.6. H2B1 is involved in the formation of microtubules, which are important for the transport of chromosomes during cell division.

H2B2, also known as H2B.p2, is a smaller isoform that is expressed in a variety of tissues, including muscle, heart, and brain. It is made up of 108 amino acids and has a pI of approximately 9.2. H2B2 is involved in the regulation of the cytoskeleton and is thought to play a role in the mechanical stability of the cell.

H2B3, also known as H2B.p3, is a less abundant isoform that is expressed in the liver and other tissues. It is made up of 96 amino acids and has a pI of approximately 9.5. H2B3 is involved in the regulation of DNA replication and may be a drug target for diseases that involve inflammation or DNA replication errors.

H2B4, also known as H2B.p4, is the least abundant isoform and is expressed in the kidney and other tissues. It is made up of 89 amino acids and has a pI of approximately 9.8. H2B4 is involved in the regulation of protein synthesis and may be a drug target for diseases that involve protein synthesis errors.

Despite its importance in the structure and function of chromosomes, H2B is not well understood. The precise function of H2B is not known, and it is not clear how it contributes to the regulation of cell processes. However, studies have suggested that H2B plays a role in the regulation of cell growth, differentiation, and inflammation.

One potential drug target for H2B is the inhibitor of the protein kinase CKL, also known as p110 subunit B (p110尾). CKL is a non-phosphotidylinositol (NPQ) kinase that is involved in the regulation of cell growth and differentiation. Studies have shown that inhibiting CKL can lead to the growth arrest and apoptosis of H2B-positive cells.

Another potential drug target for H2B is the small molecule S100, also known as p21. S100 is a non-phosphotidylinositol (NPQ) receptor that is involved in the regulation of cell growth and differentiation. Studies have shown that S100 can inhibit the activity of CKL and that this inhibition is associated with the growth arrest and apoptosis of H2B-positive cells.

In addition to its potential drug targets, H2B is also a potential biomarker for various diseases. For example, H2B is often used as a marker for the diagnosis of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. H2B is also used as a marker for the diagnosis of cancer, as it is often overexpressed in cancer cells.

Overall, H2B is a complex protein that plays a critical role in the structure and function of chromosomes. While its precise function is not yet well understood, studies have suggested that H2B is involved in the regulation of cell growth, differentiation, and inflammation. Its potential drug targets and biomarker status make it an attractive target for further research and development.

Protein Name: H2B Clustered Histone 18

Functions: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling

The "H2BC18 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about H2BC18 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

H2BC20P | H2BC21 | H2BC26 | H2BC27P | H2BC3 | H2BC4 | H2BC5 | H2BC6 | H2BC7 | H2BC8 | H2BC9 | H2BP1 | H2BP2 | H2BP3 | H2BW1 | H2BW2 | H2BW4P | H3-3A | H3-3B | H3-4 | H3-5 | H3-7 | H3C1 | H3C10 | H3C11 | H3C12 | H3C13 | H3C14 | H3C15 | H3C2 | H3C3 | H3C4 | H3C6 | H3C7 | H3C8 | H3P16 | H3P36 | H3P37 | H3P44 | H3P5 | H3P6 | H4C1 | H4C11 | H4C12 | H4C13 | H4C14 | H4C15 | H4C16 | H4C2 | H4C3 | H4C4 | H4C5 | H4C6 | H4C7 | H4C8 | H4C9 | H6PD | HAAO | HABP2 | HABP4 | HACD1 | HACD2 | HACD3 | HACD4 | HACE1 | HACL1 | HADH | HADHA | HADHAP1 | HADHB | HAFML | HAGH | HAGHL | HAGLR | HAGLROS | HAL | HAMP | HAND1 | HAND2 | HAND2-AS1 | HAO1 | HAO2 | HAO2-IT1 | HAP1 | HAPLN1 | HAPLN2 | HAPLN3 | HAPLN4 | HAPSTR1 | HAR1A | HAR1B | HARBI1 | HARS1 | HARS2 | HAS1 | HAS2 | HAS2-AS1 | HAS3 | HASPIN | HAT1